Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Purchase | 2025-03-31 | 13G | SUTRO BIOPHARMA INC STRO | BlackRock Inc. BLK | 614,361 7.300% | 31,969 (+5.49%) | Filing History |
| 2025-04-04 4:32 pm Purchase | 2025-03-28 | 13G | SUTRO BIOPHARMA INC STRO | RA Capital Management, L.P. | 443,464 5.300% | 443,464 (New Position) | Filing History |
| 2024-11-14 7:54 pm Sale | 2024-09-30 | 13G | SUTRO BIOPHARMA INC STRO | Point72 Asset Management, L.P. | 299,745 3.700% | -293,546 (-49.48%) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | SUTRO BIOPHARMA INC STRO | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -334,795 (Position Closed) | Filing History |
| 2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | SUTRO BIOPHARMA INC STRO | Rubric Capital Management LP | 0 0.000% | -334,481 (Position Closed) | Filing History |
| 2024-11-12 5:46 pm Unchanged | 2024-09-30 | 13G | SUTRO BIOPHARMA INC STRO | VANGUARD GROUP INC | 419,507 5.110% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | SUTRO BIOPHARMA INC STRO | Adage Capital Management, L.P. | 225,013 2.750% | 225,013 (New Position) | Filing History |
| 2024-11-04 4:07 pm Sale | 2024-09-30 | 13G | SUTRO BIOPHARMA INC STRO | Integrated Core Strategies (US) LLC | 203,175 2.500% | -142,008 (-41.14%) | Filing History |
| 2024-11-04 2:09 pm Purchase | 2024-09-30 | 13G | SUTRO BIOPHARMA INC STRO | VANGUARD GROUP INC | 419,507 5.110% | 419,507 (New Position) | Filing History |
| 2024-04-05 4:05 pm Purchase | 2024-04-04 | 13G | SUTRO BIOPHARMA INC STRO | Point72 Asset Management, L.P. | 593,291 7.900% | 593,291 (New Position) | Filing History |
| 2024-02-13 12:16 pm Purchase | 2023-12-31 | 13G | SUTRO BIOPHARMA INC STRO | Montanova Capital, LLC | 577,819 9.500% | 21,309 (+3.83%) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | SUTRO BIOPHARMA INC STRO | Rubric Capital Management LP | 334,481 5.490% | 13,294 (+4.14%) | Filing History |
| 2024-02-07 07:56 am Purchase | 2023-12-31 | 13G | SUTRO BIOPHARMA INC STRO | ADAGE CAPITAL PARTNERS GP L.L.C. | 446,780 7.330% | 91,848 (+25.88%) | Filing History |
| 2024-01-24 5:23 pm Purchase | 2023-12-31 | 13G | SUTRO BIOPHARMA INC STRO | BlackRock Inc. BLK | 582,392 9.600% | 96,378 (+19.83%) | Filing History |
| 2024-01-17 4:54 pm Purchase | 2024-01-10 | 13G | SUTRO BIOPHARMA INC STRO | Integrated Core Strategies (US) LLC | 345,183 5.700% | 345,183 (New Position) | Filing History |
| 2023-10-10 4:52 pm Purchase | 2023-09-28 | 13G | SUTRO BIOPHARMA INC STRO | ADAGE CAPITAL PARTNERS GP L.L.C. | 354,932 5.860% | 354,932 (New Position) | Filing History |
| 2023-02-14 3:00 pm Sale | 2022-12-31 | 13G | SUTRO BIOPHARMA INC STRO | Eventide Asset Management, LLC | 0 0.000% | -270,898 (Position Closed) | Filing History |
| 2023-02-14 11:45 am Purchase | 2022-12-31 | 13G | SUTRO BIOPHARMA INC STRO | BIOTECHNOLOGY VALUE FUND L P | 334,795 5.800% | 18,753 (+5.93%) | Filing History |
| 2023-02-13 10:56 am Purchase | 2022-12-31 | 13G | SUTRO BIOPHARMA INC STRO | Montanova Capital, LLC | 556,510 9.700% | 309,130 (+124.96%) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | SUTRO BIOPHARMA INC STRO | Rubric Capital Management LP | 321,187 5.590% | 321,187 (New Position) | Filing History |